Compositions And Methods For T Cell Delivery Of Therapeutic Molecules - EP3250681

The patent EP3250681 was granted to The Trustees OF The University OF Pennsylvania on May 3, 2023. The application was originally filed on Oct 30, 2015 under application number EP15880617A. The patent is currently recorded with a legal status of "Revoked".

EP3250681

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Application Number
EP15880617A
Filing Date
Oct 30, 2015
Status
Revoked
Jan 10, 2025
Grant Date
May 3, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEFeb 5, 2024CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2014172584
INTERNATIONAL-SEARCH-REPORTUS2009055944
INTERNATIONAL-SEARCH-REPORTUS2011280878
INTERNATIONAL-SEARCH-REPORTUS2014050709
INTERNATIONAL-SEARCH-REPORTWO2014011988
OPPOSITIONWO2012138858
OPPOSITIONWO2014172584
OPPOSITIONWO2016061574
OTHEREP3207147
OTHERUS6265138
OTHERWO2014172584
OTHERWO2016061574
SEARCHUS2014219975
SEARCHWO2014165707

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Touraj Farazmandfar, Hossein Khanahmad Shahreza, Mohammad Reza Haghshenas, Ghasem Janbabai, Hossein Azadeh, Nader Mansour Samaei, "Use of integrase-minus lentiviral vector for transient expression", Cell Journal, Royan Institute of Iran, Tehran, Tehran , (20120801), vol. 14, no. 2, ISSN 2228-5806, pages 76 - 81, XP093161282
OPPOSITION- Sabine Geisse, Bernd Voedisch, "Chapter 13. Transient Expression Technologies: Past, Present, and Future", Sabine Geisse, Bernd Voedisch, Voynov, Vladimir ; Caravella, Justin A. (eds.), Therapeutic proteins : methods and protocolsIN: Methods in molecular biology; ISSN 1940-6029; Vol. 899, US , Humana Press , (20120524), vol. 899, pages 203 - 219, doi:10.1007/978-1-61779-921-1_13, ISBN 978-1-61779-920-4, XP009554015
OPPOSITION- Joan Massagué, "TGFβ in Cancer", Cell, Elsevier, Amsterdam NL, Amsterdam NL , (20080725), vol. 134, no. 2, doi:10.1016/j.cell.2008.07.001, ISSN 0092-8674, pages 215 - 230, XP093161289
OPPOSITION- Peter ten Dijke, Caroline S Hill, "New insights into TGF-β-Smad signalling", Trends in Biochemical Sciences, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20040501), vol. 29, no. 5, doi:10.1016/j.tibs.2004.03.008, ISSN 0968-0004, pages 265 - 273, XP004506836
OPPOSITION- Trickett, A. Kwan, Y.L., "T cell stimulation and expansion using anti-CD3/CD28 beads", Journal of Immunological Methods, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM., NL, NL , (20030401), vol. 275, no. 1-2, doi:10.1016/S0022-1759(03)00010-3, ISSN 0022-1759, pages 251 - 255, XP004416755
OPPOSITION- Watford Wendy T, Moriguchi Masato, Morinobu Akio, O’shea John J, "The biology of IL-12: coordinating innate and adaptive immune responses", Cytokine & Growth Factor Reviews, Elsevier Ltd, GB, GB , (20031001), vol. 14, no. 5, doi:10.1016/S1359-6101(03)00043-1, ISSN 1359-6101, pages 361 - 368, XP055787741
OPPOSITION- Michael H. Kershaw, Jennifer A. Westwood, Phillip K. Darcy, "Gene-engineered T cells for cancer therapy", Nature Reviews Cancer, Nature Pub. Group, London, London , (20130801), vol. 13, no. 8, doi:10.1038/nrc3565, ISSN 1474-175X, pages 525 - 541, XP055543320
OPPOSITION- BACON C M ET AL, "Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (19950801), vol. 92, no. 16, doi:10.1073/pnas.92.16.7307, ISSN 0027-8424, pages 7307 - 7311, XP002216626
OPPOSITION- Zhu Hong-Jian, Andrew M. Sizeland, "A Pivotal Role for the Transmembrane Domain in Transforming Growth Factor-β Receptor Activation", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (19990423), vol. 274, no. 17, doi:10.1074/jbc.274.17.11773, ISSN 0021-9258, pages 11773 - 11781, XP093005025
OPPOSITION- PULE M, FINNEY H, LAWSON A, "ARTIFICIAL T-CELL RECEPTORS", Cytotherapy, ISIS MEDICAL MEDIA, OXFORD,, GB, GB , (20030101), vol. 05, no. 03, doi:10.1080/14653240310001488, ISSN 1465-3249, pages 211 - 226, XP008028247
OPPOSITION- Markus Chmielewski; Andreas A. Hombach; Hinrich Abken, "Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma", Immunological Reviews, Wiley-Blackwell Publishing, Inc., US, US , (20131213), vol. 257, no. 1, doi:10.1111/imr.12125, ISSN 0105-2896, pages 83 - 90, XP071455757
OPPOSITION- Gianpietro Dotti; Stephen Gottschalk; Barbara Savoldo; Malcolm K. Brenner, "Design and development of therapies using chimeric antigen receptor‐expressing T cells", Immunological Reviews, Wiley-Blackwell Publishing, Inc., US, US , (20131213), vol. 257, no. 1, doi:10.1111/imr.12131, ISSN 0105-2896, pages 107 - 126, XP071455751
OPPOSITION- Mingli Xu, "Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27", CLINICAL & DEVELOPMENTAL IMMUNOLOGY, Hindawi Publishing Corp, US, US , (20100914), vol. 2010, doi:10.1155/2010/832454, ISSN 1740-2522, pages 832454 - 9, XP093161290
OPPOSITION- Arian Sadeghi, Gustav Ullenhag, Gunnar Wagenius, Thomas H. Tötterman, Fredrik Eriksson, "Rapid expansion of T cells: Effects of culture and cryopreservation and importance of short-term cell recovery", ACTA ONCOLOGICA., INFORMA HEALTHCARE, LONDON, GB, GB , (20130601), vol. 52, no. 5, doi:10.3109/0284186X.2012.737020, ISSN 0284-186X, pages 978 - 986, XP055656852
OPPOSITION- Sylvia Lee, Kim Margolin, "Cytokines in Cancer Immunotherapy", Cancers, MDPI AG, CH, CH , (20111201), vol. 3, no. 4, doi:10.3390/cancers3043856, ISSN 2072-6694, pages 3856 - 3893, XP055215785

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents